Skip Navigation

JNCI Monographs 2006 2006(36):37-47; doi:10.1093/jncimonographs/lgj007
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Fryback, D. G.
Right arrow Articles by Remington, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fryback, D. G.
Right arrow Articles by Remington, P. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org.

Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model

Dennis G. Fryback, Natasha K. Stout, Marjorie A. Rosenberg, Amy Trentham-Dietz, Vipat Kuruchittham, Patrick L. Remington

Affiliations of authors: Departments of Population Health Sciences (DGF, NKS, ATD, PLR), Actuarial Science, Risk Management, and Insurance (MAR), Biostatistics Medical Informatics (MAR), and Industrial and Systems Engineering (DGF, VK), University of Wisconsin, Madison, WI; University of Wisconsin Comprehensive Cancer Center, Madison, WI (ATD, PLR)

Correspondence to: Dennis G. Fryback, PhD, Department of Population Health Sciences, University of Wisconsin–Madison, 610 Walnut St., Rm. 685, Madison, WI 53726 (e-mail: dfryback{at}wisc.edu).

The Wisconsin Breast Cancer Epidemiology Simulation Model is a discrete-event, stochastic simulation model using a systems-science modeling approach to replicate breast cancer incidence and mortality in the U.S. population from 1975 to 2000. Four interacting processes are modeled over time: (1) natural history of breast cancer, (2) breast cancer detection, (3) breast cancer treatment, and (4) competing cause mortality. These components form a complex interacting system simulating the lives of 2.95 million women (approximately 1/50 the U.S. population) from 1950 to 2000 in 6-month cycles. After a "burn in" of 25 years to stabilize prevalent occult cancers, the model outputs age-specific incidence rates by stage and age-specific mortality rates from 1975 to 2000. The model simulates occult as well as detected disease at the individual level and can be used to address "What if?" questions about effectiveness of screening and treatment protocols, as well as to estimate benefits to women of specific ages and screening histories.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
J. S. Mandelblatt, K. A. Cronin, S. Bailey, D. A. Berry, H. J. de Koning, G. Draisma, H. Huang, S. J. Lee, M. Munsell, S. K. Plevritis, et al.
Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms
Ann Intern Med, November 17, 2009; 151(10): 738 - 747.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. M. Kaplan and F. Porzsolt
The Natural History of Breast Cancer
Arch Intern Med, November 24, 2008; 168(21): 2302 - 2303.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
P.-H. Zahl, J. Maehlen, and H. G. Welch
The Natural History of Invasive Breast Cancers Detected by Screening Mammography
Arch Intern Med, November 24, 2008; 168(21): 2311 - 2316.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. N.A. Tosteson, N. K. Stout, D. G. Fryback, S. Acharyya, B. A. Herman, L. G. Hannah, E. D. Pisano, and for the DMIST Investigators
Cost-Effectiveness of Digital Mammography Breast Cancer Screening
Ann Intern Med, January 1, 2008; 148(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. J. Kim, E. L. Franco, N. K. Stout, and S. J. Goldie
THE AUTHORS REPLY
Am. J. Epidemiol., October 15, 2007; 166(8): 983 - 984.
[Full Text] [PDF]


Home page
JCOHome page
A. B. Knudsen, P. M. McMahon, and G. S. Gazelle
Use of Modeling to Evaluate the Cost-Effectiveness of Cancer Screening Programs
J. Clin. Oncol., January 10, 2007; 25(2): 203 - 208.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
E. J. Feuer
Chapter 1: Modeling the Impact of Adjuvant Therapy and Screening Mammography on U.S. Breast Cancer Mortality Between 1975 and 2000: Introduction to the Problem
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 2 - 6.
[Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
L. D. Clarke, S. K. Plevritis, R. Boer, K. A. Cronin, and E. J. Feuer
Chapter 13: A Comparative Review of CISNET Breast Models Used To Analyze U.S. Breast Cancer Incidence and Mortality Trends
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 96 - 105.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
J. D. F. Habbema, S. Y. G. L. Tan, and K. A. Cronin
Chapter 14: Impact of Mammography on U.S. Breast Cancer Mortality, 1975-2000: Are Intermediate Outcome Measures Informative?
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
K. A. Cronin, E. J. Feuer, L. D. Clarke, and S. K. Plevritis
Chapter 15: Impact of Adjuvant Therapy and Mammography on U.S. Mortality From 1975 to 2000: Comparison of Mortality Results From the CISNET Breast Cancer Base Case Analysis
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 112 - 121.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.